Currently out of the existing stock ratings of Emily Bodnar, 266 are a BUY (85.81%), 44 are a HOLD (14.19%).

Emily Bodnar

Work Performance Price Targets & Ratings Chart

Analyst Emily Bodnar, carries an average stock price target met ratio of 34.27% that have a potential upside of 57.28% achieved within 114 days. Previously, Emily Bodnar worked at HC WAINWRIGHT.

Emily Bodnar’s has documented 537 price targets and ratings displayed on 30 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AGIO, Agios Pharm at 12-Feb-2026.

Wall Street Analyst Emily Bodnar

Analyst best performing recommendations are on BCTX (BRIACELL THERAPEUTICS CORP).
The best stock recommendation documented was for OLMA (OLEMA PHARMACEUTICALS) at 10/20/2025. The price target of $28 was fulfilled within 37 days with a profit of $20.23 (260.36%) receiving and performance score of 70.37.

Average potential price target upside

DICE Dice Molecules Holdings LLC FEMY Femasys NVCR Novocure Ltd OLMA Olema Pharmaceuticals VTYX Ventyx Biosciences SQZ Sqz Biotechnologies Co ACLX Arcellx BCTX Briacell Therapeutics Corp CNTX Context Therapeutics GRCL Gracell Biotechnologies INKT Mink Therapeutics IOBT IO Biotech NKTX Nkarta  RNAZ Transcode Therapeutics AGEN Agenus SANA Sana Biotechnology JSPR Jasper Therapeutics ANAB AnaptysBio RCUS Arcus Biosciences GERN Geron NXTC NextCure  ATOS Atossa Genetics CNTB Connect Biopharma Holdings Ltd ACRV Acrivon Therapeutics, Common Stock GNLX Genelux Common Stock PPBT Purple Biotech SLRN ACELYRIN, INC. Common Stock AGIO Agios Pharm RAPT RAPT Therapeutics VTVT vTv Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 21-Jun-2023

$48

$0.45 (0.95%)

$48

2 years 6 months 15 days ago
(09-Aug-2023)

1/8 (12.5%)

$0.45 (0.95%)

85

Hold Since 26-Jun-2023

$56

2 years 7 months 29 days ago
(26-Jun-2023)

0/1 (0%)

$27.35 (95.46%)

Hold Since 20-Jun-2023

$48

$0.45 (0.95%)

$68

2 years 8 months 4 days ago
(20-Jun-2023)

1/3 (33.33%)

$1.56 (3.36%)

27

Hold Since 24-May-2023

$48

$0.45 (0.95%)

$38

2 years 8 months 4 days ago
(20-Jun-2023)

1/2 (50%)

$1.56 (3.36%)

27

Hold Since 20-Jun-2023

$48

$0.45 (0.95%)

$71

2 years 8 months 4 days ago
(20-Jun-2023)

0/2 (0%)

$1.56 (3.36%)

Show more analysts

Please expand the browser size to see the chart

Which stock is Emily Bodnar is most bullish on?

Potential upside of $50.89 has been obtained for ACLX (ARCELLX)

Which stock is Emily Bodnar is most reserved on?

Potential downside of -$3.19 has been obtained for ANAB (ANAPTYSBIO)

What Year was the first public recommendation made by Emily Bodnar?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?